Invention Grant
- Patent Title: Treatment of C. difficile toxin B associated conditions
-
Application No.: US85032Application Date: 1998-05-28
-
Publication No.: US6013635APublication Date: 2000-01-11
- Inventor: Louis D. Heerze , Glen D. Armstrong
- Applicant: Louis D. Heerze , Glen D. Armstrong
- Applicant Address: CAX Calgary
- Assignee: Synsorb Biotech, Inc.
- Current Assignee: Synsorb Biotech, Inc.
- Current Assignee Address: CAX Calgary
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/7016 ; A61K31/702 ; A61K31/715 ; A61K47/48 ; A61P1/04 ; A61P1/12 ; A61P39/02
Abstract:
This invention relates to prevention and/or treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD), pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection, using oligosaccharide compositions which bind C. difficile toxin B. More specifically, the invention concerns neutralization of C. difficile toxin B associated with such conditions.
Public/Granted literature
- US5432280A Gel-forming silicone composition Public/Granted day:1995-07-11
Information query
